AU2002363928A1 - Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same - Google Patents

Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same

Info

Publication number
AU2002363928A1
AU2002363928A1 AU2002363928A AU2002363928A AU2002363928A1 AU 2002363928 A1 AU2002363928 A1 AU 2002363928A1 AU 2002363928 A AU2002363928 A AU 2002363928A AU 2002363928 A AU2002363928 A AU 2002363928A AU 2002363928 A1 AU2002363928 A1 AU 2002363928A1
Authority
AU
Australia
Prior art keywords
compositions
preparing
methods
same
nucleic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002363928A
Other languages
English (en)
Other versions
AU2002363928A8 (en
Inventor
Deepa Deshpande
Igor Gonda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aradigm Corp
Original Assignee
Aradigm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aradigm Corp filed Critical Aradigm Corp
Publication of AU2002363928A1 publication Critical patent/AU2002363928A1/en
Publication of AU2002363928A8 publication Critical patent/AU2002363928A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002363928A 2001-11-21 2002-11-15 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same Abandoned AU2002363928A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/990,181 US20030096774A1 (en) 2001-11-21 2001-11-21 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same
US09/990,181 2001-11-21
PCT/US2002/036529 WO2003045965A2 (en) 2001-11-21 2002-11-15 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same

Publications (2)

Publication Number Publication Date
AU2002363928A1 true AU2002363928A1 (en) 2003-06-10
AU2002363928A8 AU2002363928A8 (en) 2003-06-10

Family

ID=25535873

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002363928A Abandoned AU2002363928A1 (en) 2001-11-21 2002-11-15 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same

Country Status (6)

Country Link
US (2) US20030096774A1 (enExample)
EP (1) EP1453845A4 (enExample)
JP (1) JP2005511644A (enExample)
AU (1) AU2002363928A1 (enExample)
CA (1) CA2467677A1 (enExample)
WO (1) WO2003045965A2 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
PT1458360E (pt) * 2001-12-19 2011-07-13 Novartis Ag Derivados de indole como agonistas do recetor s1p1
JP2005530704A (ja) * 2002-03-05 2005-10-13 トランセイブ， インク． 細胞内感染を予防及び治療するための吸入システム
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
PT1581236E (pt) * 2002-10-29 2013-12-24 Insmed Inc Libertação prolongada de anti-infecciosos
WO2005060573A2 (en) * 2003-12-15 2005-07-07 University Of Medicine And Dentistry Of New Jersey Pna-neamine conjugates and methods for producing and using the same
US20080226605A1 (en) * 2005-05-19 2008-09-18 Dev Priya Arya Methods and Compositions Facilitating Entry of Compounds Into Cells
EP3067047B1 (en) 2005-12-08 2022-04-20 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections
CA2885621C (en) * 2007-03-30 2016-01-05 Hirofumi Takeuchi Transpulmonary liposome for controlling drug arrival
WO2008137717A1 (en) 2007-05-04 2008-11-13 Transave, Inc. Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9789194B2 (en) 2007-11-27 2017-10-17 Rutgers, The State University Of New Jersey Graft copolymer polyelectrolyte complexes for drug delivery
US9271933B2 (en) * 2007-11-27 2016-03-01 Rutgers, The State University Of New Jersey Graft copolymer polyelectrolyte complexes for drug delivery
US8979797B2 (en) * 2010-12-16 2015-03-17 Ams Research Corporation High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics
PL2852391T3 (pl) 2012-05-21 2022-04-11 Insmed Incorporated Układy do leczenia infekcji płuc
US10124066B2 (en) 2012-11-29 2018-11-13 Insmed Incorporated Stabilized vancomycin formulations
CN103272238B (zh) * 2013-06-08 2015-04-15 北京大学 基于dna与氨基糖苷类分子复合物的生物材料
LT3466432T (lt) 2014-05-15 2020-12-28 Insmed Incorporated Būdai, skirti plaučių netuberkuliozinėms mikobakterinėms infekcijoms gydyti
EP3180364B1 (en) * 2014-08-12 2019-07-17 The Regents of the University of California Multifunctional membrane-active aminoglycoside-peptide conjugates
EP3773505B1 (en) 2018-03-30 2026-04-29 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
JP7449275B2 (ja) 2018-05-02 2024-03-13 インスメッド インコーポレイテッド リポソーム薬物製剤の製造方法
DE102018113243A1 (de) 2018-06-04 2019-12-05 BIOCHEM Zusatzstoffe Handels- und Produktionsgesellschaft mbH Verfahren zur Herstellung einer Zusammensetzung enthaltend zumindest eine Metall-Aminosäure-Verbindung sowie Zusammensetzung erhältlich durch ein derartiges Verfahren

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4400375A (en) * 1981-11-23 1983-08-23 Eli Lilly And Company Tobramycin-double stranded RNA complex suitable for inducing interferon
US5469854A (en) * 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
US5756353A (en) * 1991-12-17 1998-05-26 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol-and liposome-based delivery
WO1994011384A1 (en) * 1992-11-13 1994-05-26 Immunex Corporation Novel cytokine designated elk ligand
US6015686A (en) * 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems
US6070575A (en) * 1998-11-16 2000-06-06 Aradigm Corporation Aerosol-forming porous membrane with certain pore structure

Also Published As

Publication number Publication date
JP2005511644A (ja) 2005-04-28
US20050019926A1 (en) 2005-01-27
US20030096774A1 (en) 2003-05-22
EP1453845A2 (en) 2004-09-08
CA2467677A1 (en) 2003-06-05
EP1453845A4 (en) 2005-11-09
AU2002363928A8 (en) 2003-06-10
WO2003045965A3 (en) 2004-01-08
WO2003045965A2 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
AU2002363928A1 (en) Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same
AU2003228772A1 (en) Merchandisers having anti-fog coatings and methods for making the same
AU2002326877A1 (en) Novel nucleic acids and polypeptides
AU2002314709A1 (en) Novel nucleic acids and polypeptides
AU2002357119A1 (en) Mitocidal compositions and methods
AU2003270310A1 (en) Compositions and methods for synthesizing nucleic acids
AU2002343417A1 (en) Novel nucleic acids and polypeptides
AU2002365081A1 (en) Anti-icing coatings and methods
AU2001245987A1 (en) Compositions and methods for gene therapy
AU2002353310A1 (en) Method for the preparation of nucleic acids
GB2387597B (en) Stereoselective preparation of 3-hydroxy-3-phenylpropionitrile
AU2001260774A1 (en) Bio-support and preparing method of the same
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU6611500A (en) Single-phase amplification of nucleic acids
AU2756301A (en) Compositions comprising genome segments and methods of using the same
AU2002311759A1 (en) Methods and compositions for analyzing nucleic acids
AU2710400A (en) Monocyte-derived nucleic acids and related compositions and methods
AU2002227318A1 (en) Haplotypes of the cyp2d6 gene
AU2600100A (en) Methods and compositions for delivering nucleic acids
AU2002338007A1 (en) Surface for the immobilisation of nucleic acids
AU4007899A (en) Compositions and methods for the pulmonary delivery of nucleic acids
AU2001259595A1 (en) Haplotypes of the crybb1 gene
EP1549761A4 (en) METHOD AND COMPOSITIONS FOR MODIFYING NUCLEAR SULFURES
AU2002303827A1 (en) Compositions and methods for extension of nucleic acids
AU2002359869A1 (en) Pak5-related compositions and methods

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase